Events

08:15 - 08:45

Arrival & Check‐in at AbbVie main entrance and reception (Sudermannstrasse)

08:45 - 09:15

Welcome and Introduction

Fenja Klima: From trial design to clinical practice: Informing optimal therapy for novel and established anticancer drugs through modelling and simulation
Johannes Tillil: Reducing the dimensionality of QSP models while retaining their main mechanistic features

10:45 – 11:15

Zrinka Duvnjak: Dosing regimen optimisation of vedolizumab during pregnancy through physiologically-motivated sequential population modelling of albumin trends and vedolizumab pharmacokinetics

12:00 – 13:30

Session I, building 11 - room 23/24: Joint PharMetrX Partner Meeting (Steering Board and Industry Partners Representatives)
Session II, building 34 - room 217: PhD student workshop with Pharmacometrics Group at AbbVie

Joint Coffee/Tea break

Session I and Session II, to be continued
(same rooms as before)

Wrap‐up & Closing (all participants, building 11 - room 23/24)

End